Search
Close this search box.

Update on Detection of the Latest SARS-CoV-2 Variant BA.2.86

Singapore, September 7, 2023 – Update on Detection of the Latest SARS-CoV-2 Variant Credo Diagnostics Biomedical Pte Ltd is committed to the post-market monitoring of the reliability of our assays. We have performed nucleotide analysis using the BLASTn method, comparing primers and probes of the assays involving SARS-CoV-2 virus detection to all sequences listed in […]